Identifying and classifying patients with ILD early is critical for timely intervention1,2

Early Identification

baseline clinical values upon suspicion or diagnosis of ILD to identify future progression using tools such as PFTs and HRCT imaging3,4


the lungs proactively and routinely for progressive fibrosis2,5


individual ILDs according to their disease behavior to help assess prognosis1

Diagram Identification

HRCT, high-resolution computed tomography; ILD, interstitial lung disease; PFT, pulmonary function tests; SSc-ILD, systemic sclerosis-associated interstitial lung disease.

References: 1. Travis WD et al. Am J Respir Crit Care Med. 2013;188(6):733-748. 2. Meyer KC. Transl Respir Med. 2014;2(4):1-13. 3. Wells AU. Thorax. 2008;63(suppl V):v1-v58. 4. Silver KC. Rheum Dis Clin North Am. 2015;41(3):439-457. 5. Raghu G et al. Am J Respir Crit Care Med. 2011;183(6):788-824. 6. Wells AU et al. Eur Respir J. 2018;0:1-12. 7. Flaherty KR et al. BMJ Open Resp Res. 2017;4(1):1-7.